Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

Golf, often a game of patience and calculated risks, has a way of humbling even the greatest players. Just when it seems like ...

Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, gastrointestinal (GI) and hematology, while pushing the Japanese company’s cell ...

Rio Takeda shot a blistering 8-under 64 to win the LPGA’s Blue Bay tournament by six shots ahead of Minjee Lee of Australia.

Takeda’s $300 million bet on Protagonist Therapeutics’ hematology asset a year ago appears to have paid off as the drug ...

Rio Takeda hinted at what she was capable of last fall. She proved it Sunday in China. The 21-year-old rookie from Japan ...

Rio Takeda of Japan shot a 3-under 69 to hold a two-shot lead after three rounds of the LPGA’s Blue Bay tournament on China’s ...

LPGA Tour rookie Rio Takeda carded an 8-under-par 64 on Sunday to cruise to a six-stroke victory at the Blue Bay LPGA on ...

Takeda paid Protagonist $300 million one year ago to license rights to rusfertide, which the companies are developing to ...

Takeda made it rain zebras at a Boston Celtics game Friday. The stunt saw 100 toy zebras parachute from the arena’s rafters ...

Takeda—the 21-year-old Japanese golfer with great bloodlines—turned a two-shot lead after 54 holes into a six-shot lead five holes into her final round. Takeda fired an 8-under 64 to win in dominant ...

SANYA, China — Rio Takeda shot a blistering 8-under 64 on Sunday to win the LPGA’s Blue Bay tournament by six shots ahead of ...